Pages that link to "Q42991104"

The following pages link to Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay (Q42991104):

Displaying 38 items.

• Analytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen Quantification (Q27491329) (← links)
• Identification of New Functional Regions in Hepatitis C Virus Envelope Glycoprotein E2 (Q27666330) (← links)
• HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes (Q33645428) (← links)
• Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia (Q33766292) (← links)
• NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly (Q33828601) (← links)
• Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors (Q34262175) (← links)
• Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions (Q34295953) (← links)
• Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients (Q34475736) (← links)
• Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection (Q35119678) (← links)
• Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patients (Q35689119) (← links)
• Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C (Q35716330) (← links)
• Hepatitis C Virus Core Mutations Associated with False-Negative Serological Results for Genotype 3a Core Antigen (Q35868727) (← links)
• Japanese reference panel of blood specimens for evaluation of hepatitis C virus RNA and core antigen quantitative assays (Q36022842) (← links)
• Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples (Q36554189) (← links)
• Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein. (Q36559948) (← links)
• Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging. (Q37682493) (← links)
• Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications (Q37822462) (← links)
• Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment (Q38221492) (← links)
• Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly (Q38717202) (← links)
• HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study (Q39321794) (← links)
• Can Hepatitis C Virus Antigen Testing Replace Ribonucleic Acid Polymearse Chain Reaction Analysis for Detecting Hepatitis C Virus? A Systematic Review (Q39342907) (← links)
• Identifying cost-effective screening algorithms for active hepatitis C virus infections in a high prevalence setting (Q40053596) (← links)
• Performance comparison of new generation HCV core antigen test versus HCV RNA test in management of hepatitis C virus infection (Q40273765) (← links)
• Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C. (Q40580971) (← links)
• Hepatitis C virus core antigen assay: an alternative method for hepatitis C diagnosis (Q40587141) (← links)
• Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics (Q41015358) (← links)
• Mechanisms of methods for hepatitis C virus inactivation (Q41589435) (← links)
• Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania. (Q41929470) (← links)
• Hepatitis C virus core antigen testing in liver and kidney transplant recipients (Q42254574) (← links)
• Clinico-pathological significance of hepatitis C virus core antigen levels in chronic infection (Q42280536) (← links)
• Breaking Down Barriers to Care in Hepatitis C Virus Infection (Q42645615) (← links)
• Therapy-induced clearance of HCV core antigen from plasma predicts an end of treatment viral response. (Q42987172) (← links)
• HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs (Q44998162) (← links)
• Hepatitis C virus: Morphogenesis, infection and therapy. (Q52661702) (← links)
• Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain (Q56926489) (← links)
• HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies (Q57067254) (← links)
• The correlation of HCV RNA and HCV core antigen in different genotypes of HCV (Q59355514) (← links)
• Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam (Q59793304) (← links)